Skip to main content
Clinical Trials/CTRI/2024/02/062831
CTRI/2024/02/062831
Not yet recruiting
Phase 4

A double blinded randomized controlled study to assess safety and effectiveness of carbetocin vs oxytocin during active management of third stage, for prevention of PPH in patients undergoing cesarean section - nil

siddaganga medical college and research institute0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: O82- Encounter for cesarean delivery without indication
Sponsor
siddaganga medical college and research institute
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
siddaganga medical college and research institute

Eligibility Criteria

Inclusion Criteria

  • willing to participate
  • gestational age 36 weeks\-41 weeks
  • patients undergoing cesarean section

Exclusion Criteria

  • hypertensive
  • pre eclampsia
  • ante partum hemorrhage
  • bleeding disorders
  • thrombocytopenia
  • blood coagulation abnormalities
  • cardiovascular disorders
  • renal disease
  • liver disease
  • general anesthesia

Outcomes

Primary Outcomes

Not specified

Similar Trials